Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
What a stupid post Leroy, the conferences are to share the promising findings of SNG001. I can assure you plenty will be interested in the amount of lives this can save. Conferences are not going to lead to any form of commercialisation they’re to share the data synairgen have found from their trials. More trials are needed these conferences are paving the way to get to the much needed trials and potential JV’s. If you’ve got the patience needed to see this across the line then I’d suggest selling up because it’s not happening anytime soon, these things take time.
@manifesto it is all over Twitter news links that it is legionaries disease and a lot of ‘maybe’ legionaries disease.. This morning there is reports of being over 20 cases now which must be a concern about how this is spreading and what it actual is.
Manifesto I know on the RNS it states funded by janssen but on the Southampton hospital website trial details it states ‘This trial is funded by Janssen Pharmaceuticals and AstraZeneca, with support in kind from Synairgen Ltd.’ Support in kind could mean synairgen still have operational cost such as wages of staff involvement etc.. So just ignore my comment I was just being sceptical hopefully janssen are covering all costs.
It would be interesting to have insights into the cost implications for synairgen this will have over the coming years.
Without a platform trial there is no route to commercialisation and revenue without asking shareholders for more funds. Fingers crossed we have platform inclusion news in the coming weeks!
I disagree OJ, it shows that synairgen are highly respected in the field of respiratory disease. If they didn’t have any knowledge and expertise to help in this trial then the big pharma would of gone at it alone and not needed there input.
The news this morning is a great development for synairgen and for people who understand this is going to take time in investigating, promoting SNG001 and trialing SNG001. This is a massive step and most expect this to be the first of many good bits of news in the coming months.
The reason for the spike and sell is due to to many expecting 2020 gains again in 2023, it’s not going to happen like that, we are in a total different place now to then. A lot stronger in my opinion now we have this investigational trial ongoing and if we get onto a platform trial treating with SNG001.
Patience will be rewarded. GLTA.
This is obviously a real worry and problem for the world.
But this is a win, win for Synairgen. If this virus takes a hold and there is no treatments working currently at reducing severity then I’d assume SNG001 would be leading the charge of potential therapeutics to reduce severity to get trialed. If it fizzled out and stayed localised in Argentina then it highlights the edge knife the world stands on with new viruses and highlights how drugs such as SNG001 need further testing and approving ready for the next big thing.
Interesting weeks ahead.
I worry about some of you, every time I check in it’s the same people bickering the same sh*t no matter what day, or what time of day. It’s been like that all year, there is more to life than this board.
I think some of you should try take a break from this board for your own mental health.
A few weeks away here has worked wonders for me. It seems I have not missed anything other than the daily back and forth a from the same posters, what is nice to see is LTH who have been away for awhile beginning to drop back in.
News soon and my personal opinion is they have seen enough LC data to know it needs a professional writer to promote and get the most out of the data they will be releasing.
Hopefully good times to come. LC, platform news and activ news.
GLTA, logging off until we get news.
Got to agree with you there monteacute. Since February when we got top line results and a total collapse in the SP there hasn’t been anything really. We had some good data in deep dive and a decent presentation at ATS other than that in 5 months we’ve had nothing from them. Long hold but can see why people will be getting sick of holding this stock now. They don’t give much and we are just expected to hope that there enthusiasm at the AGM is enough to warrant a positive outcome long term.
How 5 months after top line data can we still be waiting for long covid results ? How long is the expectation to getting this data is anyone aware ?
If you have been reading this board for a while then you’d know what the positives are. Right now not a great deal. The main positive is the general consensus we will be getting on at least 1, if not more than 1 paid trial. It depends on how much you know about to Synairgen whether you believe they will get on a trial or not.
Maybe so Ghia, whether you are sitting on a loss or not there is no need to push a negative narrative. All up for both sides of the coin and good discussions I just feel something off with your posting. Let’s leave it there.
Chia I would disagree completely. At the minute the discussions are realistic and balanced. You clearly haven’t been active much lately as the people in discussion since the AGM are not those who was asking for RM’s head as I remember.
I once saw you as one of the best contributors on here but this weekend I feel you are pushing an alternative narrative and picking fault with posters comments when there is no need.
No one is saying they expect to see £2+ this summer just that we have news due which will begin to move the SP north of today price. You seem to be picking fault unnecessarily with these comments.
I find it strange you’ve not contributed much at all this year to my memory to then come in this weekend so argumentative and disruptive. I know you are a LTH so are not pushing the negatives on purpose all I can assume is you’re sitting on a fair loss and are losing patience here. Some people here are on big losses to but would rather discuss the upcoming positives without the negative spin.
We are adults and are not expecting a quick turnaround here.